MassDevice

InBrain Neuroelectronics completes enrollment in first-in-human BCI trial

InBrain Neuroelectronics announced today that it completed patient recruitment in a first-in-human brain-computer interface ...
Interesting Engineering on MSN

First-in-human study confirms safety of graphene-based brain interface

Spain-based INBRAIN Neuroelectronics has completed patient recruitment for its first-in-human study evaluating a ...
Morningstar

First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes

BOSTON, March 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel minimally invasive treatments for neurological diseases, today announced the publication ...

Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain

The device could help address multiple neurological conditions if it proves successful. One early use could be delivering ...
Business Insider

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
The Manila Times

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study

High Impact Session presented at Heart Rhythm Society's Congress in ChicagoFirst time showing results of new Less Invasive ...
Morningstar

VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis

VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis VS3 Medical, Inc., a private company developing novel ...
MassDevice

Phantom Neuro can begin first-in-human neural interface trial

Phantom Neuro announced today that it received approval to conduct a first-in-human study of its neural interface in ...
UUHC Health Feed

First Three Patients Treated with Novel Theranostics Drug in First-in-Human Clinical Trial

The first three patients in the world have been treated in a Phase 1 clinical trial of RYZ401. RYZ401 is a novel radiopharmaceutical that specifically targets somatostatin receptors on neuroendocrine ...